ABSTRACT
BACKGROUND
Home wireless device monitoring could play an important role in improving the health of patients with poorly controlled chronic diseases, but daily engagement rates among these patients may be low.
OBJECTIVE
To test the effectiveness of two different magnitudes of financial incentives for improving adherence to remote-monitoring regimens among patients with poorly controlled diabetes.
DESIGN
Randomized, controlled trial. (Clinicaltrials.gov Identifier: NCT01282957).
PARTICIPANTS
Seventy-five patients with a hemoglobin A1c greater than or equal to 7.5 % recruited from a Primary Care Medical Home practice at the University of Pennsylvania Health System.
INTERVENTIONS
Twelve weeks of daily home-monitoring of blood glucose, blood pressure, and weight (control group; n = 28); a lottery incentive with expected daily value of $2.80 (n = 26) for daily monitoring; and a lottery incentive with expected daily value of $1.40 (n = 21) for daily monitoring.
MAIN MEASURES
Daily use of three home-monitoring devices during the three-month intervention (primary outcome) and during the three-month follow-up period and change in A1c over the intervention period (secondary outcomes).
KEY RESULTS
Incentive arm participants used devices on a higher proportion of days relative to control (81 % low incentive vs. 58 %, P = 0.007; 77 % high incentive vs. 58 %, P = 0.02) during the three-month intervention period. There was no difference in adherence between the two incentive arms (P = 0.58). When incentives were removed, adherence in the high incentive arm declined while remaining relatively high in the low incentive arm. In month 6, the low incentive arm had an adherence rate of 62 % compared to 35 % in the high incentive arm (P = 0.015) and 27 % in the control group (P = 0.002).
CONCLUSIONS
A daily lottery incentive worth $1.40 per day improved monitoring rates relative to control and had significantly better efficacy once incentives were removed than a higher incentive.
Similar content being viewed by others
REFERENCES
Asch DA, Muller RW, Volpp KG. Automated hovering in health care: watching over the 5,000 hours. N Engl J Med. 2012;367:1–3.
Miliard M. Automated at-home monitoring lowers high blood pressure, study finds. Available at: http://www.healthcareitnews.com/news/automated-home-monitoring-lowers-high-blood-pressure-study-finds. Accessed January 13, 2014.
Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3(6):1460–71.
Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146(4):705–12.
Schwedes U, Siebolds M, Mertes G, SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25(11):1928–32.
de Lusignan S, Wells S, Johnson P, Meredith K, Leatham E. Compliance and effectiveness of 1 year’s home telemonitoring. The report of a pilot study of patients with chronic heart failure. Eur J Heart Fail. 2001;3(6):723–30.
Davidson MB, Castellanos M, Kain D, Duran P. The effect of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422–5.
Nyce S. Boosting wellness participation without breaking the bank. Towers Watson Insider. Available at http://www.towerswatson.com/en/Insights/Newsletters/Americas/Insider/2010/boosting-wellness-participation-without-breaking-the-bank. Accessed January 13, 2014.
Volpp KG, John LK, Troxel AB, Norton L, Fassbender J, Loewenstein G. Financial incentive-based approaches for weight loss: a randomized trial. JAMA. 2008;300(22):2631–7.
Volpp KG, Loewenstein G, Troxel AB, et al. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008;8:272.
Kimmel SE, Troxel AB, Loewenstein G, et al. Randomized trial of lottery-based incentives to improve warfarin adherence. Am Heart J. 2012;164(2):268–74.
Asch DA, Volpp KG. On the Way to Health. LDI Issue Brief. July/August 2012. Volume 17, Issue 9.
Chapman GB, Coups EJ. Emotions and preventive health behavior: worry, regret, and influenza vaccination. Health Psychol. 2006;25(1):82–90.
Zeelenberg M, Pieters R. Consequences of regret aversion in real life: the case of the Dutch postcode lottery. Organ Behav Hum Decis Process. 2004;93:155–68.
Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica. 1979;47:263–91.
Connolly T, Butler DU. Regret in economic and psychological theories of choice. J Behav Decis Mak. 2006;19(2):148–58.
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22.
Zeger SL, Liang KY. The analysis of discrete and continuous longitudinal data. Biometrics. 1986;42:121–30.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.
John LK, Loewenstein G, Troxel AB, Norton L, Fassbender JE, Volpp KG. Financial incentives for extended weight loss: a randomized, controlled trial. J Gen Intern Med. 2011;26(6):621–6.
Kullgren JT, Troxel AB, Loewenstein G, et al. Individual- versus group-based financial incentives for weight loss: a randomized, controlled trial. Ann Intern Med. 2013;158(7):505–14.
Eisenberger R, Cameron J. Detrimental effects of reward: reality or myth? Am Psychol. 1996;51(11):1153–66.
Deci EL, Ryan RM. Intrinsic Motivation and Self-Determination in Human Behavior. New York, NY: Plenum Press; 1985.
Lepper MR, Greene D, Nisbett RE. Undermining children’s intrinsic interest with extrinsic reward. J Pers Soc Psychol. 1973;28(1):129–37.
Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627–68.
Gneezy U, Meier S, Rey-Biel P. When and why incentives (don’t) work to modify behavior. J Econ Perspect. 2011;25(4):1–21.
Acknowledgements
Contributors
We thank Paula Gray, MSN, CRNP and Amanda Parent, MSN, CRNP for their participation in and support of this study.
Funders
This work was supported by grants RC2AG036592 and P30AG034546 from the National Institute on Aging.
Prior presentations
We presented an earlier version of this paper on a research panel at AcademyHealth’s 2013 Annual Research Meeting in Baltimore, MD in June, 2013.
Conflict of Interest
The authors declare that they do not have a conflict of interest. Drs. Asch, Loewenstein, and Volpp have served as consultants for VAL Health, and Drs. Loewenstein and Volpp have served as consultants for CVS Caremark. Dr. Volpp has also received research funding from Weight Watchers, CVS Caremark, Humana, Horizon BCBS, and McKinsey, none of which is directly related to the subject of this study. Dr. Loewenstein has also received research funding from CVS Caremark and Humana. The other authors (Sen, Sewell, Riley, Stearman, Bellamy, Hu, Park, Tao, and Zhu) have no financial disclosures or other conflicts of interest to report.
Author information
Authors and Affiliations
Corresponding author
Additional information
Clinicaltrials.gov Identifier: NCT01282957.
Rights and permissions
About this article
Cite this article
Sen, A.P., Sewell, T.B., Riley, E.B. et al. Financial Incentives for Home-Based Health Monitoring: A Randomized Controlled Trial. J GEN INTERN MED 29, 770–777 (2014). https://doi.org/10.1007/s11606-014-2778-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-014-2778-0